PAIN JOINTS SPINE · Jun 22, 2026
Ayurvedic Prevention and Management of Bone and Joint Degeneration: A Systematic Review
By Singh DB, Singh DV, Pandey CS et al.
Background. Osteoarthritis and osteoporosis are the leading age-related musculoskeletal disorders worldwide, with rising prevalence driven by population ageing; current pharmacotherapy is largely symptomatic and guidelines prioritise non-pharmacological prevention. Ayurveda offers a coherent preventive framework for bone (asthi) and joint (sandhi) health, but its concepts and practices are unevenly mapped to contemporary evidence. This review synthesises the Ayurvedic framework, its preventive diet and regimen, and age-related management, alongside their scientific validation, using the WHO International Standard Terminologies on Ayurveda for nomenclature. Materials and methods. A structured review was conducted following PRISMA-oriented principles. PubMed/MEDLINE, Scopus, Web of Science, EMBASE, EBSCO and the Cochrane Library were searched (2015–2026) combining classical Ayurvedic constructs (asthi dhatu, sandhigata vata, asthi kshaya, rasayana, basti, abhyanga) with biomedical terms (osteoarthritis, osteoporosis, bone mineral density, randomized controlled trial, meta-analysis). Systematic reviews, meta-analyses and randomized/controlled clinical trials were prioritised; Ayurvedic terms were standardised against the WHO International Standard Terminologies on Ayurveda (2022). Results. Ayurvedic etiopathogenesis maps closely onto modern bone biology: asthi dhatu kshaya corresponds to osteoporosis and sandhigata vata to osteoarthritis, with bone-tissue metabolism (asthidhatvagni) paralleling osteoblast–osteoclast remodelling. Among preventive measures, anti-inflammatory/Mediterranean-type dietary patterns reduced incident osteoarthritis and supported bone mineral density; dietary sesame (~40 g/day) lowered pain and inflammatory markers in knee osteoarthritis; and yoga improved pain, stiffness and function across eight randomized controlled trials (756 patients), though trial quality was modest. A confirmatory multicentre randomized controlled trial found a complex Ayurvedic regimen superior to conventional care for knee osteoarthritis, with effects sustained to 12 months, albeit confounded by greater therapist-contact time. For age-related management, Boswellia serrata and curcumin showed the strongest, clinically important symptom benefit; Cissus quadrangularis showed the best bone-specific data; collagen peptides demonstrated medium-term benefit; ashwagandha improved knee symptoms; while glucosamine/chondroitin gave inconsistent effects, and vitamin D/calcium remained foundational for bone rather than joints. Recurrent limitations were small samples, industry funding, geographic concentration and difficulty blinding manual therapies. Conclusions. The non-pharmacological pillars of the Ayurvedic framework—anti-inflammatory diet, moderate exercise/yoga and oil-based regimen—rest on firmer evidence than its individual herbs and align with mainstream prevention, while the integrated whole-system approach has the single strongest confirmatory trial. Standardising Ayurvedic nomenclature via WHO-ITA terminology enables reproducible, evidence-based integration for bone and joint health in ageing populations. Well-designed, adequately blinded prevention trials are warranted.